|
GEMIN8P4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.429600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.174000E-02 |
| Normal-vs-Stage2 |
7.218200E-01 |
| Normal-vs-Stage3 |
9.371800E-01 |
| Normal-vs-Stage4 |
2.800400E-02 |
| Stage1-vs-Stage2 |
2.897800E-01 |
| Stage1-vs-Stage3 |
1.329800E-01 |
| Stage1-vs-Stage4 |
1.606040E-02 |
| Stage2-vs-Stage3 |
7.050200E-01 |
| Stage2-vs-Stage4 |
4.581400E-01 |
| Stage3-vs-Stage4 |
7.001800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.623790E-01 |
| Normal-vs-AfricanAmerican |
1.228990E-01 |
| Normal-vs-Asian |
3.973800E-01 |
| Caucasian-vs-AfricanAmerican |
5.514200E-01 |
| Caucasian-vs-Asian |
6.850000E-02 |
| AfricanAmerican-vs-Asian |
4.441600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.283600E-01 |
| Normal-vs-Female |
1.118820E-01 |
| Male-vs-Female |
3.698000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.331400E-01 |
| Normal-vs-Extreme_Weight |
6.809900E-02 |
| Normal-vs-Obese |
3.853500E-02 |
| Normal-vs-Extreme_Obese |
7.462200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.356600E-01 |
| Normal_Weight-vs-Obese |
1.620800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.236600E-01 |
| Extreme_Weight-vs-Obese |
5.118400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.789200E-01 |
| Obese-vs-Extreme_Obese |
4.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.805800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.301800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.339030E-01 |
| Normal-vs-Age(81-100Yrs) |
4.111900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.174100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.621700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.345500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.739400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.421600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.850800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.965000E-01 |
| Normal-VS-Type2 PRCC |
5.046300E-02 |
| Normal-VS-KIRP CIMP |
1.513210E-01 |
| Normal-VS-Unclassified PRCC |
8.979800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.504760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.923760E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.949800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.411940E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.646640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.713600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.763400E-01 |
| Normal-vs-N1 |
4.770400E-01 |
| Normal-vs-N2 |
6.468000E-01 |
| N0-vs-N1 |
4.315800E-01 |
| N0-vs-N2 |
8.653200E-01 |
| N1-vs-N2 |
5.458000E-01 |
|
|
